New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett's oesophagus

Gut

Volumn 55, Issue 4, 2006, Pages 442-443

  Playford, R J ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ESOMEPRAZOLE;

BARRETT ESOPHAGUS; CANCER GROWTH; CANCER RISK; CLINICAL TRIAL; DISEASE SURVEILLANCE; DOSE RESPONSE; ESOPHAGOSCOPY; HUMAN; INTESTINE METAPLASIA; MEDICAL SOCIETY; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; UNITED KINGDOM;

BARRETT ESOPHAGUS; ESOPHAGOSCOPY; GREAT BRITAIN; HUMANS; PRACTICE GUIDELINES; SOCIETIES, MEDICAL;

EID: 33645131562     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.083600     Document Type: Note

References (3)

1. Guidelines for the diagnosis and management of Barrett's columnar lined oesophagus. A report of the working party of the British Society of Gastroenterology. http://www.bsg.org.uk (accessed 17 January 2006).
2. Sampliner RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1998;93:1028-32.
3. Shepherd NA. Biddlestone LR. The histopathology and cytopathology of Barrett's oesophagus. In, Manek S, eds. CPD bulletin cellular pathology London, Rila Publications, 1999:39-44.